… reports that treatment with psychostimulants is not associ… the depressed medically ill patient,
in this case, cancer patients.… criteria to decide which patients receive psychostimulants, and …

… In contrast with this high prevalence, evidence for efficacy of antidepressants is limited
and future research on the use of psychostimulant in cancer patients is needed. …

… In this article, we review data relating to psychostimulants (… ) in the treatment of depression.
Differences between modafinil and … depressed patients with advanced cancer; the depressive …

… Psychostimulants have also been examined for the treatment of depression in patients with
cancer. In one … was used in patients with advanced cancer identified as being depressed by a …

… psychostimulants like caffeine and the novel wake-promoting drug, modafinil. Studies evaluating
use of these drugs in cancer patients … depression in palliative care cancer patients have …

… PREVALENCE RATES for major depression syndromes in cancer patients range from 4%
to 58%.Several explanations are given for this wide range, including variations in …

… the long-term safety of psychostimulants). They posit that methylphenidate may have a
clinically useful effect in relieving depressive symptoms in advanced cancer patients, but point out …

… review of the use of psychostimulant agents for fatigue among patients with cancer, including
an … disorders, as an adjunct treatment of bipolar depression, and in patients with persistent …

… In patients treated with psychostimulants may counteract sedation and potentiate the
analgesic effects. Side effects include insomnia, anxiety and agitation, tachycardia, and rarely …

… depression in the cancer patient, how it affects the course and prognosis of the primary
cancer … In one study, 12 59 hospitalized, depressed patients who used psychostimulants were …